Viewing StudyNCT04666649



Ignite Creation Date: 2024-05-06 @ 3:32 PM
Last Modification Date: 2024-10-26 @ 1:51 PM
Study NCT ID: NCT04666649
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-08
First Post: 2020-12-07

Brief Title: Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia RR AML
Sponsor: University of Maryland Baltimore
Organization: University of Maryland Baltimore

Conditions & Keywords Data

Conditions:
Name
Relapsed or Refractory Acute Myeloid Leukemia
Keywords:
Name View
Pegcrisantaspase View
Venetoclax View
Relapsed or refractory acute myeloid leukemia RR AML View
Ven-PegC View
Maximum tolerated doses View
Recommended phase 2 doses View
Incidence of regimen limiting toxicities View
Incidence of treatment-emergent adverse events View